Sunday, November 17, 2024

CATEGORY

NYSE Updates

Allstate stock downgraded to Hold, price target stays at $200 By Investing.com

On Wednesday, Allstate Corporation (NYSE:) experienced a change in stock rating as CFRA downgraded the insurance giant from Buy to Hold,...

Starbucks draws analyst upgrades on ‘home run hire’ of new chief executive

Stifel, Deutsche Bank, CFRA and TD Cowen analysts hiked ratings on the coffee giant after it named Brian Niccol as its new chief...

Morgan Stanley sees 31% upside for Flutter shares after impressive quarterly results By Investing.com

On Wednesday, a Morgan Stanley analyst increased the price target for Flutter Entertainment Plc (FLTR:LN) (NYSE: FLUT) shares to £191.00 from the previous...

Justice Department considering breaking up Google, among other options: report

The Justice Department is weighing a potential breakup of Google, among other options, Bloomberg News reported on Tuesday.

Intel Corporation to Participate in Upcoming Investor Conferences By Investing.com

SANTA CLARA, Calif.--(BUSINESS WIRE)--Intel Corporation today announced that company executives will participate in the following investor events:On Aug. 29 at 8 a.m....

Why the bull market in stocks can continue despite a brutal start to August

“The pullback in August doesn’t need to be the start of something worse,” said Angelo Kourkafas, a senior investment strategist at Edward Jones.

BTIG reaffirms ‘Buy’ on Flutter Entertainment stock ahead of earnings report By Investing.com

On Tuesday, BTIG reiterated its Buy rating on Flutter Entertainment (NYSE:FLUT) stock with a steady price target of $245.00. The firm's stance comes...

Trump praises Tesla, worries about how much power AI uses in glitchy chat with Elon Musk

Billionaire entrepreneur and Donald Trump supporter Elon Musk spoke with Trump for more than two hours in a wide-ranging conversation on Monday night...

Orion S.A. hit by $60 million wire fraud By Investing.com

Orion S.A. (NYSE:OEC), a company specializing in miscellaneous chemical products, disclosed today a significant financial setback due to a criminal scheme targeting an...

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

Shares of companies developing treatments based on psilocybin and other psychedelic drugs moved lower on Monday after the U.S. Food and Drug Administration...

Latest news